124 related articles for article (PubMed ID: 32670103)
1. The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change.
McIntyre RS; Subramaniapillai M; Park C; Zuckerman H; Cao B; Lee Y; Iacobucci M; Nasri F; Fus D; Bowie CR; Tran T; Rosenblat JD; Mansur RB
Front Psychiatry; 2020; 11():546. PubMed ID: 32670103
[TBL] [Abstract][Full Text] [Related]
2. The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder.
Cao B; Park C; Subramaniapillai M; Lee Y; Iacobucci M; Mansur RB; Zuckerman H; Phan L; McIntyre RS
Front Psychiatry; 2019; 10():17. PubMed ID: 30766492
[No Abstract] [Full Text] [Related]
3. Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it).
Cha DS; Carmona NE; Mansur RB; Lee Y; Park HJ; Rodrigues NB; Subramaniapillai M; Rosenblat JD; Pan Z; Lee JH; Lee J; Almatham F; Alageel A; Shekotikhina M; Zhou AJ; Rong C; Harrison J; McIntyre RS
Scand J Pain; 2017 Apr; 15():62-67. PubMed ID: 28850348
[TBL] [Abstract][Full Text] [Related]
4. The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disorder.
McIntyre RS; Best MW; Bowie CR; Carmona NE; Cha DS; Lee Y; Subramaniapillai M; Mansur RB; Barry H; Baune BT; Culpepper L; Fossati P; Greer TL; Harmer C; Klag E; Lam RW; Wittchen HU; Harrison J
J Clin Psychiatry; 2017 Jul; 78(7):873-881. PubMed ID: 28858441
[TBL] [Abstract][Full Text] [Related]
5. Association between cognitive function and performance on effort based decision making in patients with major depressive disorder treated with Vortioxetine.
Subramaniapillai M; Mansur RB; Zuckerman H; Park C; Lee Y; Iacobucci M; Cao B; Ho R; Lin K; Phan L; McIntyre RS
Compr Psychiatry; 2019 Oct; 94():152113. PubMed ID: 31404802
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with objective and subjective cognitive impairment in Chinese patients with acute major depressive disorder.
Zhu N; Tong J; Pei Y; Zhang J; Sun X
BMC Psychiatry; 2023 May; 23(1):348. PubMed ID: 37208711
[TBL] [Abstract][Full Text] [Related]
7. Cognitive Deficits in the THINC-Integrated Tool (THINC-it) Are Associated With Psychosocial Dysfunction in Patients With Major Depressive Disorder.
Knight MJ; Fourrier C; Lyrtzis E; Aboustate N; Sampson E; Hori H; Mills NT; Baune BT
J Clin Psychiatry; 2018 Nov; 80(1):. PubMed ID: 30549482
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder.
Cha DS; Carmona NE; Subramaniapillai M; Mansur RB; Lee Y; Hon Lee J; Lee J; Rosenblat JD; Shekotikhina M; Park C; Rong C; Greer TL; Lam R; Baune BT; Harrison J; McIntyre RS
J Affect Disord; 2017 Nov; 222():14-20. PubMed ID: 28667888
[TBL] [Abstract][Full Text] [Related]
9. PSYCHOMETRIC properties of the Chinese version of the THINC-it tool for cognitive symptoms in patients with major depressive disorder.
Hou Y; Yao S; Hu S; Zhou Q; Han H; Yu X; McIntyre RS; Shi C
J Affect Disord; 2020 Aug; 273():586-591. PubMed ID: 32560957
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder.
McIntyre RS; Florea I; Tonnoir B; Loft H; Lam RW; Christensen MC
J Clin Psychiatry; 2017 Jan; 78(1):115-121. PubMed ID: 27780334
[TBL] [Abstract][Full Text] [Related]
11. An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study.
McIntyre RS; Lipsitz O; Rodrigues NB; Subramaniapillai M; Nasri F; Lee Y; Fehnert B; King J; Chrones L; Kratiuk K; Uddin S; Rosenblat JD; Mansur RB; McCue M
JMIR Ment Health; 2022 Oct; 9(10):e33871. PubMed ID: 36301615
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Vortioxetine on Cognitive Function in Patients with Major Depressive Disorder: A Meta-Analysis of Three Randomized Controlled Trials.
McIntyre RS; Harrison J; Loft H; Jacobson W; Olsen CK
Int J Neuropsychopharmacol; 2016 Jun; 19(10):. PubMed ID: 27312740
[TBL] [Abstract][Full Text] [Related]
13. Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial.
Cao B; Park C; Rosenblat JD; Chen Y; Iacobucci M; Subramaniapillai M; Mansur RB; Zuckerman H; Lee Y; McIntyre RS
J Psychopharmacol; 2019 Nov; 33(11):1388-1394. PubMed ID: 31530216
[TBL] [Abstract][Full Text] [Related]
14. Exploratory study of association between blood immune markers and cognitive symptom severity in major depressive disorder: Stratification by body mass index status.
Fourrier C; Sampson E; Hori H; Schubert KO; Clark S; Mills NT; Baune BT
Brain Behav Immun; 2020 Aug; 88():242-251. PubMed ID: 32526448
[TBL] [Abstract][Full Text] [Related]
15. The Relationship Between Cognitive Dysfunction Through THINC-Integrated Tool (THINC-it) and Psychosocial Function in Chinese Patients With Major Depressive Disorder.
Han H; Hou Y; Yao S; Hu S; Zhou Q; Yu X; McIntyre RS; Shi C
Front Psychiatry; 2021; 12():763603. PubMed ID: 34887790
[No Abstract] [Full Text] [Related]
16. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in Major Depressive Disorder.
Cha DS; Carmona NE; Rodrigues NB; Mansur RB; Lee Y; Subramaniapillai M; Phan L; Cha RH; Pan Z; Lee JH; Lee J; Almatham F; Alageel A; Rosenblat JD; Shekotikhina M; Rong C; Harrison J; McIntyre RS
J Affect Disord; 2018 Oct; 238():228-232. PubMed ID: 29886204
[TBL] [Abstract][Full Text] [Related]
17. Validation of the THINC-It Tool for Assessment of Cognitive Impairment in Patients with Bipolar Depression.
Zhu N; Zhang W; Huang J; Su Y; Lu J; Yang L; Shi Y; Hu S; Chen J; Fang Y
Neuropsychiatr Dis Treat; 2023; 19():443-452. PubMed ID: 36874958
[TBL] [Abstract][Full Text] [Related]
18. Reliability and Validity of THINC-it in Evaluating Cognitive Function of Patients with Bipolar Depression.
Zhang W; Zhu N; Lai J; Liu J; Ng CH; Chen J; Qian C; Du Y; Hu C; Chen J; Hu J; Wang Z; Zhou H; Xu Y; Fang Y; Shi C; Hu S
Neuropsychiatr Dis Treat; 2020; 16():2419-2428. PubMed ID: 33116541
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of vortioxetine in patients with major depressive disorder and comorbid Alzheimer's disease in routine clinical practice: An analysis of a post-marketing surveillance study in South Korea.
Cumbo E; Adair M; Åstrom DO; Christensen MC
Front Aging Neurosci; 2022; 14():1037816. PubMed ID: 36698860
[TBL] [Abstract][Full Text] [Related]
20. Randomized, double-blind, placebo-controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder.
Inoue T; Sasai K; Kitagawa T; Nishimura A; Inada I
Psychiatry Clin Neurosci; 2020 Feb; 74(2):140-148. PubMed ID: 31725942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
